fbpx
November 8, 2022

Brain Imaging Validates Cognitive Problems After Lyme Disease Brain Imaging Validates Cognitive Problems After Lyme Disease

New imaging data show distinctive brain changes that appear to explain memory and cognitive problems following Lyme disease. Using fMRI and diffusion tensor imaging (DTI) techniques, […]
November 7, 2022

Even Mild MS Relapses May Signal Faster Disability Accumulation Even Mild MS Relapses May Signal Faster Disability Accumulation

Nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis (RRMS) signal faster accumulation of disability relative to no early relapses, new research suggests. […]
November 7, 2022

MS Meds in Breastfeeding Mothers Safe for Infants MS Meds in Breastfeeding Mothers Safe for Infants

Breastfeeding by women with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMSOD) who are taking anti-CD20 IgG1 monoclonal antibodies (mAb) appears to be safe for […]
November 7, 2022

Novel Intervention Relieves Depression in MS Patients Novel Intervention Relieves Depression in MS Patients

An internet-based cognitive-behavioral therapy (iCBT) program specifically designed for patients with multiple sclerosis (MS) significantly reduced depressive symptoms compared to usual treatment, new research shows. Participants […]
November 4, 2022

‘Tantalizing’ New Data for Ibudilast in Multiple Sclerosis ‘Tantalizing’ New Data for Ibudilast in Multiple Sclerosis

Ibudilast has a significant beneficial effect on slowly evolving lesions (SELs) in patients with progressive multiple sclerosis (MS), new data suggest. Through its effect on SELs, […]
November 3, 2022

Stroke Risk Rises With Years of Drinking in Young Adults Stroke Risk Rises With Years of Drinking in Young Adults

Young adults who are moderate to heavy drinkers are at increased risk of suffering a stroke — and the risk goes up with more years of […]
November 3, 2022

New Research Confirms Recommendations on COVID Boosters in MS New Research Confirms Recommendations on COVID Boosters in MS

New research confirms the importance of COVID-19 mRNA booster doses for patients with multiple sclerosis (MS) who are receiving the anti-CD20 monoclonal antibody ocrelizumab (Ocrevus), as […]
November 3, 2022

New CDC Guidance on Prescribing Opioids for Pain New CDC Guidance on Prescribing Opioids for Pain

The US Centers for Disease Control and Prevention (CDC) has released updated and expanded recommendations for prescribing opioids for adults with acute and chronic pain not […]
November 2, 2022

Traffic-Related Pollutant Tied to Increased Dementia Risk Traffic-Related Pollutant Tied to Increased Dementia Risk

Exposure to a traffic-related air pollutant significantly increases risk for dementia, new research suggests. Results from a meta-analysis, which included a total of more than 90 […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0